The Supreme Court invited the Solicitor General to weigh in on the Court of Appeals for the Federal Circuit’s decision in GlaxoSmithKline v. Teva Pharms. The Solicitor General’s brief took the position that the Supreme Court should grant Teva’s petition for a writ of certiorari.